A phase 1b study of tbio-4101 (autologous selected and expanded tumor-infiltrating lymphocytes [TILs]) with pembrolizumab in patients with anti-PD-1–resistant, advanced head and neck squamous cell carcinoma (aHNSCC)
Kirtane, Kedar, Verdon, Ines, Hall, Maclean, Pilon-Thomas, Shari, Baldonado, Jobelle Joyce Anne, Rabinowits, Guilherme, Chung, Christine H.
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
A phase 1/2 study of RTX-224, an engineered red blood cell expressing 4-1BB ligand and membrane-bound IL-12, for the treatment of patients with select advanced solid tumors
Spira, Alexander I., Johnson, Melissa Lynne, Ren, Ai, Sundaresan, Varsha, Verdon, Ines, Turka, Laurence, Elloul, Sivan
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
A phase I/II first-in-human trial of oral SRA737 (a Chk1 inhibitor) given in combination with low-dose gemcitabine in subjects with advanced cancer
Banerji, Udai, Plummer, Elizabeth Ruth, Moreno, Victor, Ang, Joo Ern, Quinton, Amy, Drew, Yvette, Hernández, Tatiana, Roda, Desamparados, Carter, Louise, Navarro, Alejandro, Kristeleit, Rebecca Sophie, Arkenau, Hendrik-Tobias, Sarker, Debashis, Castellano, Daniel E., Walter, Harriet, Roxburgh, Patricia, Blagden, Sarah Patricia, Anthoney, Alan, Verdon, Ines, Jones, Robert Hugh
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
A first-in-human phase I/II trial of SRA737 (a Chk1 Inhibitor) in subjects with advanced cancer
Plummer, Elizabeth Ruth, Kristeleit, Rebecca Sophie, Cojocaru, Elena, Haris, Noor Md, Carter, Louise, Jones, Robert Hugh, Blagden, Sarah Patricia, Evans, T.R. Jeffry, Arkenau, Hendrik-Tobias, Sarker, Debashis, Danson, Sarah, Symeonides, Stefan N., Walter, Harriet, Ocen, Joanita, Randhawa, Manreet, Kowalski, Mark Marion, Verdon, Ines, Dye, Andrew, Banerji, Udai
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article